OXFORD BIOMEDICA PLC (OXB.L)

Every figure this model derived for OXB.L, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2025-12-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 4,761,000 PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities 2025-12-31
cash 96,884,000 CashAndCashEquivalents 2026-01-01
current assets 185,648,000 CurrentAssets 2026-01-01
current liabilities 84,220,000 CurrentLiabilities 2026-01-01
equity 91,346,000 EquityAttributableToOwnersOfParent 2026-01-01
interest expense 14,634,000 FinanceCosts 2025-12-31
ocf 507,000 CashFlowsFromUsedInOperatingActivities 2025-12-31
revenue 168,741,000 Revenue 2025-12-31

The ratios

The figures themselves rather than their scores — what somebody looking up OXB.L on one particular measure came for.

RatioValue
cash operating margin-13.32
current ratio2.2
current ratio reported2.2
ev owner earnings-124.83
ev sales3.15
fcf margin-2.52
interest cover-1.54
operating margin-13.32
owner earnings margin-2.52
revenue growth31.01
revenue growth per share31.01
roic-49.41
rule of 4017.69
sbc pct revenue0.0

What to be careful about

What this model itself distrusts about OXB.L's figures. Written by the derivation as it ran, not added afterwards.